The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s11523-014-0329-6
Published Online: 2014-08-01
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Smith, Donald L.
Acquaviva, Jaime
Sequeira, Manuel
Jimenez, John-Paul
Zhang, Chaohua
Sang, Jim
Bates, Richard C.
Proia, David A.
License valid from 2014-08-01